Pfizer (PFE) Acquisition of Medivation (MDVN) Provides Support to Biotech Stocks…Update-1 IBB Down 3.36%
Update-1 After Close 8/24 IBB at 286.23 XBI down 4.34% XLV down 1.54%, NASDAQ down 0.81% Early Afternoon Reversal Kills Biotech Rally In Heavy Trading But Mylan is not a biotech Company?? The broad based rally in biotech stocks faded around 1P EDT Wednesday as investors were spooked by the...
Today’s Movers in Life Sciences-Gene Sequencing: ILMN,PACB
Illumina (ILMN) Up 3 % to $174 on Buyout Speculation in Gene Sequencing Illumina, Inc. (ILMN) was up as much as 12 points earlier today on a rumored buyout from Thermo Fisher Scientific Inc. (TMO). Thermo bought another major player in sequencing Life Techologies for $13.6B making it the...
Large Cap Biopharmaceutical Metrics: Valuation Models for Future Growth
Large Cap Biopharmaceutical Valuation Models Can Biotech Growth Re-accelerate in Q4? We reviewed large cap biotech stocks on July 3 just after the BREXIT bottom but prior to Q2 earnings and on May 8 after Q1 earnings. Here is data that offer comparisons of the core large cap holdings in the...
Biotech Breakout Part 2: Hold Your Fire…Update 8/15/16
Update August 15 : Biotech Leads But Healthcare Sector Lags IBB up 0.92% to $295, XBI up 1.33% to $63.35, XLV up 0.17% to $74.91 The tape was pretty decent despite a quiet day with ALXN up 1.97%, AMGN up 1.49% and CELG up 1.08%. Mid-caps also found bids: ALKS up 2.91%,ALNY up 2.16% and VRTX up...
Biotech Breakout: Is the Bull Market Back?…Update-1 IBB,BMY
8/5 After the Close... NASDAQ Up 1.06% The IBB inched up 0.38% to $297.29 while the more volatile XBI did better up 1.07%. Both are still down YTD and trail the QQQ which is up 4.39% YTD. Investors in biotech were not deterred by bad clinical news from Bristol-Myers (BMY) down 16% to $63.28....